SDRI GIVES A REASON FOR HOPE IN 2021 ANNUAL REPORT

SDRI Features Important Work in Diabetes Research

Sansum Diabetes Research Institute (SDRI) released its 2021 Annual Report that highlights its efforts to improve the lives of people with diabetes and deliver much needed resources to the diabetes community. Despite the challenges in 2021, SDRI was able to expand its successful research in the Artificial Pancreas, Diabetes in Pregnancy, and groundbreaking programs in socioeconomically disadvantaged, high-risk minorities.

“We continue to make strides in diabetes research, and we were able to deliver much needed resources to our diabetes community,” said Ellen Goodstein, Executive Director. “In 2021, we continued our research and engaged 4,510 research participants and provided care for 158 women who lived with diabetes during pregnancy. SDRI is incredibly grateful for the philanthropic support for new ideas, new research, and the ability to continue Dr. Sansum’s legacy in diabetes research.”

The report also highlights the key clinical research initiatives in 2021, including the formation of the Santa Barbara Nutrition Health Coalition in 2021, which aims to generate evidence-based nutritional solutions to improve the health of people living in Santa Barbara County.

SDRI continues to be on the cutting edge of research for those living with type 1 diabetes, and the 2021 Annual Report highlights several key publications of the work conducted in 2021. These publications include results from the pivotal safety study of the first tubeless, on-body automated insulin delivery system with customizable glycemic targets, results from the first ever Continuous Ketone Monitoring device shown to work in humans, and patient-reported outcomes in a randomized trial of close-loop control.

SDRI expanded its team in 2021, and welcomed renowned pediatric endocrinologist, Dr. Francine Kaufman. Dr. Kaufman is treating patients with type 1 diabetes at SDRI and is working closely with SDRI’s Pediatric Diabetes Team.

Continued efforts to improve glucose control and navigate changes in glucose levels and insulin use throughout pregnancy are a priority for SDRI, and the 2021 Annual Report highlights the collaborative work done in the field of diabetes in pregnancy. This work includes a significant and pivotal multi-center study looking at the insulin use and glucose sensor metrics in pregnant women with type 1 diabetes using continuous glucose monitors and insulin pumps.

The report also features key work done in the local Santa Barbara community, including vaccinating local residents against the virus that causes COVID-19, beginning with priority populations and hard-to-reach groups. SDRI held 26 vaccination clinics and administered 2,294 doses of the COVID-19 vaccine, prioritizing Hispanic and Latino populations with type 1 or type 2 diabetes.

The report underscores SDRI’s key supporters and donors whose generosity helped facilitate new ideas, new research, and the ability to continue Dr. Sansum’s legacy in diabetes research and gives reason for hope.

To view SDRI’s Annual Report please visit https://www.sansum.org/annualreport2021.